Editorial: The NLRP3 inflammasome-mediated neuroinflammation and its related mitochondrial impairment in neurodegeneration

被引：1
|
作者：
Deng, Chao [1 ,2 ]
Cai, Xiang [3 ]
Jin, Kunlin [4 ]
Wang, Qing [5 ]
机构：
[1] Univ Wollongong, Sch Med Indigenous & Hlth Sci, Wollongong, NSW, Australia
[2] Illawarra Hlth & Med Res Inst, Antipsychot Res Lab, Wollongong, NSW, Australia
[3] Capital Med Univ, Beijing Inst Brain Disorders, Ctr Depress, Adv Innovat Ctr Human Brain Protect,Collaborat Inn, Beijing, Peoples R China
[4] Univ North Texas Hlth Sci Ctr, Dept Pharmacol & Neurosci, Ft Worth, TX 76107 USA
[5] Southern Med Univ, Zhujiang Hosp, Dept Neurol, Guangzhou, Guangdong, Peoples R China
来源：
FRONTIERS IN AGING NEUROSCIENCE | 2023年 / 14卷
关键词：
neurodegeneration; NLRP3; neuroinflammation; mitochondrial; delta-opioid receptors; aging;
D O I：
10.3389/fnagi.2022.1118281
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Ergolide covalently binds NLRP3 and inhibits NLRP3 inflammasome-mediated pyroptosis
    Ren, Miao
    Chen, Jiahao
    Xu, Haowen
    Li, Weifeng
    Wang, Tingting
    Chi, Zhanghuan
    Lin, Yi
    Zhang, Anqi
    Chen, Gaozhi
    Wang, Xu
    Sun, Xiaoyu
    Liang, Guang
    Wang, Junlu
    Luo, Wu
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 120
  • [12] HIV-1 Tat Primes and Activates Microglial NLRP3 Inflammasome-Mediated Neuroinflammation
    Chivero, Ernest T.
    Guo, Ming-Lei
    Periyasamy, Palsamy
    Liao, Ke
    Callen, Shannon E.
    Buch, Shilpa
    JOURNAL OF NEUROSCIENCE, 2017, 37 (13): : 3599 - 3609
  • [13] Polygala saponins inhibit NLRP3 inflammasome-mediated neuroinflammation via SHP-2-Mediated mitophagy
    Qiu, Wen-Qiao
    Ai, Wei
    Zhu, Feng-Dan
    Zhang, Yue
    Guo, Min-Song
    Law, Betty Yuen-Kwan
    Wu, Jian-Ming
    Wong, Vincent Kam-Wai
    Tang, Yong
    Yu, Lu
    Chen, Qi
    Yu, Chong-Lin
    Liu, Jian
    Qin, Da-Lian
    Zhou, Xiao-Gang
    Wu, An-Guo
    FREE RADICAL BIOLOGY AND MEDICINE, 2022, 179 : 76 - 94
  • [14] Ticagrelor alleviates neuroinflammation after traumatic brain injury by inhibiting NLRP3 inflammasome-mediated pyroptosis
    Zhu, Shenghao
    Hu, Zhaopeng
    Xu, Shengxuan
    Tu, Yiming
    NEUROREPORT, 2025, 36 (06) : 306 - 313
  • [15] Microglial SCAP deficiency protects against diabetes-associated cognitive impairment through inhibiting NLRP3 inflammasome-mediated neuroinflammation
    Zhu, Wenwen
    Zhang, Haoqiang
    Niu, Tong
    Liu, Kunyu
    Farooqui, Huzaifa Fareeduddin Mohammed
    Sun, Ruoyu
    Chen, Xiu
    Yuan, Yang
    Wang, Shaohua
    BRAIN BEHAVIOR AND IMMUNITY, 2024, 119 : 154 - 170
  • [16] The roles of NLRP3 inflammasome-mediated signaling pathways in hyperuricemic nephropathy
    Wen, Li
    Yang, Hongliu
    Ma, Liang
    Fu, Ping
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2021, 476 (03) : 1377 - 1386
  • [17] HIRUDIN ALLEVIATES ACUTE ISCHEMIC STROKE BY INHIBITING NLRP3 INFLAMMASOME-MEDIATED NEUROINFLAMMATION: IN VIVO AND IN VITRO APPROACHES
    Li, W.
    Zhang, Z. -J.
    INTERNATIONAL JOURNAL OF STROKE, 2022, 17 (3_SUPPL) : 163 - 164
  • [18] Fluvastatin Causes NLRP3 Inflammasome-Mediated Adipose Insulin Resistance
    Henriksbo, Brandyn D.
    Lau, Trevor C.
    Cavallari, Joseph F.
    Denou, Emmanuel
    Chi, Wendy
    Lally, James S.
    Crane, Justin D.
    Duggan, Brittany M.
    Foley, Kevin P.
    Fullerton, Morgan D.
    Tarnopolsky, Mark A.
    Steinberg, Gregory R.
    Schertzer, Jonathan D.
    DIABETES, 2014, 63 (11) : 3742 - 3747
  • [19] Wuzi Yanzong pill relieves motor dysfunction and neuron loss by inhibiting NLRP3 inflammasome-mediated neuroinflammation
    Fan, Hui-Jie
    Pan, Tao
    Xiao, Qi
    Xu, Lei
    Qin, Shao-Chen
    Yang, Li-Xia
    Jin, Xiao-Ming
    Xiao, Bao-Guo
    Zhang, Bo
    Ma, Cun-Gen
    Chai, Zhi
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
  • [20] Beneficial Properties of Phytochemicals on NLRP3 Inflammasome-Mediated Gout and Complication
    Jhang, Jhih-Jia
    Lin, Jia-Hong
    Yen, Gow-Chin
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2018, 66 (04) : 765 - 772
12345